Innate Pharma News

Innate Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Caisse des dépôts et consignations(9.0%),Bpifrance Participations S.A.(8.0%), etc.

Dec 6, 2022 11:52 ET

Innate Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Caisse des dépôts et consignations(10.0%),Bpifrance Participations S.A.(8.0%), etc.

Oct 21, 2022 12:58 ET

Innate Pharma | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

Feb 12, 2021 14:35 ET

Innate Pharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 3, 2020 07:00 ET

Innate Pharma | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

Oct 25, 2019 14:36 ET

Innate Pharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Oct 23, 2019 16:08 ET

Innate Pharma | D: Filing D

Jan 31, 2014 12:47 ET